Incidence and risk factors for methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis.

被引：0
|
作者：
Cannon, GW
Cerveny, KC
Finck, BK
Simpson, KM
Strand, V
机构：
[1] VA & Univ Utah, Salt Lake City, UT USA
[2] Immunex Corp, Seattle, WA USA
[3] Aventis, Bridgewater, NJ USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [21] A comparison of the renal effects of leflunomide, methotrexate, and sulfasalazine during treatment of rheumatoid arthritis.
    Schiff, M
    Whelton, A
    Strand, V
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S351 - S351
  • [22] Methotrexate-Induced Pseudotumor Cerebri and Psychosis in a Case of Rheumatoid Arthritis
    Sur, Shravani
    Chauhan, Amit
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 24 (04) : E18 - E18
  • [23] Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis
    Cron, RQ
    Sherry, DD
    Wallace, CA
    JOURNAL OF PEDIATRICS, 1998, 132 (05): : 901 - 902
  • [24] Methotrexate-Induced Pneumonitis in Rheumatoid Arthritis Long-term Treatment With Tofacitinib Therapy
    Vinicki, Juan Pablo
    Papagno, Maria Julia
    Estevez, Adrian Jorge
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) : S426 - S427
  • [25] Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis
    Taniguchi, K
    Usui, Y
    Matsuda, T
    Suzuki, S
    Fujiki, K
    Yakusiji, F
    Tomiyama, J
    Kinoshita, K
    Iizuka, H
    Kuga, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (03) : 101 - 105
  • [26] Methotrexate-induced Accelerated Nodulosis in a Patient with Rheumatoid Arthritis and Scleroderma
    Motegi, Sei-ichiro
    Ishikawa, Osamu
    ACTA DERMATO-VENEREOLOGICA, 2014, 94 (03) : 357 - 358
  • [27] Stratification of methotrexate-induced oral ulcers in rheumatoid arthritis patients
    Magdy, Eman
    Ali, Shereen
    SPECIAL CARE IN DENTISTRY, 2021, 41 (03) : 367 - 371
  • [28] Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity
    Wiczer, Tracy
    Dotson, Emily
    Tuten, Amy
    Phillips, Gary
    Maddocks, Kami
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (03) : 430 - 436
  • [29] Methotrexate-induced oral mucositis in rheumatoid arthritis disease: Therapeutic strategy in a case report
    Biasotto, M. (m.biasotto@fmc.units.it), 1600, Walter de Gruyter GmbH (02):
  • [30] Rheumatoid arthritis associated interstitial lung disease: 1 year is too much to exclude methotrexate-induced pulmonary involvement
    Kuwal, Ashok
    Dutt, Naveen
    Chauhan, Nishant
    LUNG INDIA, 2016, 33 (04) : 467 - U143
12345